Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Apply
Lutetium Lu 177 Edotreotide
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step